Membio Inc. is a Canadian startup founded in 2018 with the slogan "Scalable single-use bioreactors." The company is revolutionizing the future of medicine by facilitating the easier and more cost-effective growth of cells. Membio's single-use benchtop bioreactor system is designed to specifically address the high manufacturing costs associated with cell and gene therapies, which have been a barrier to reaching many patients in need. The last investment Membio received was a $3.22M Seed Round investment on 20 April 2020, with notable investors including SOSV, VU Venture Partners, True Ventures, indiebio, Boom Capital Ventures, and Ramen Ventures. The company operates in the Biotechnology, Health Care, Manufacturing, and Pharmaceutical industries. Membio's groundbreaking approach shows promise in addressing critical challenges in the healthcare sector and is likely to attract further attention from prominent investors and stakeholders in the future.
No recent news or press coverage available for Membio Inc..